Hematologic Malignancies Market to Reach USD 128.48 Billion by 2032, Driven by Immunotherapy, CAR-T, and Precision Oncology - Credence Research Inc. [Yahoo! Finance]
Forget Amarin: This Oft-Overlooked Pharma Powerhouse Is a Better Buy Now [Yahoo! Finance]
Beacon Therapeutics appoints Ryan Robinson as Chief Financial Officer [Yahoo! Finance]
Novartis (NVS) Announces Plans to Establish a New Radioligand Therapy Manufacturing Site in Denton, Texas [Yahoo! Finance]
OCT West Coast: China's clinical trial infrastructure delivers upto 60% cost savings [Yahoo! Finance]